{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:10:14Z","timestamp":1785345014763,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":204,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004809","name":"Finep","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinsp.2024.100470","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T12:40:51Z","timestamp":1723293651000},"page":"100470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and validation of a liquid chromatography coupled to a diode array detector (LC-DAD) method for measuring mitotane (DDD) in plasma samples"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4995-6857","authenticated-orcid":false,"given":"Anna Sylvia Ferrari","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atecla Nunciata Lopes","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice Bilharinho","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5292-2571","authenticated-orcid":false,"given":"Helena Panteliou","family":"Lima-Valassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinsp.2024.100470_bib0001","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/bcp.14454","article-title":"On precision dosing of oral small molecule drugs in oncology","volume":"87","author":"Lyashchenko","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100470_bib0002","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jc.2010-2676","article-title":"Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study","volume":"96","author":"Hermsen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100470_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196931","article-title":"CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells","volume":"13","author":"Germano","year":"2018","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.clinsp.2024.100470_bib0004","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.3390\/cancers13215255","article-title":"Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies","volume":"13","author":"Lo Iacono","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100470_bib0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/separations8050063","article-title":"Determination of mitotane (DDD) and principal metabolite by a simple HPLC-UV method and its validation in human plasma samples","volume":"8","author":"Luci","year":"2021","journal-title":"Separations"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100470_bib0006","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-11-0557","article-title":"High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3-months of follow-up","volume":"166","author":"Maucl\u00e8re-Denost","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100470_bib0007","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s13318-021-00700-5","article-title":"The challenging pharmacokinetics of mitotane: an old drug in need of new packaging","volume":"46","author":"Haider","year":"2021","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100470_bib0008","first-page":"2234","article-title":"Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer","volume":"85","author":"Terzolo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100470_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0277-5379(84)90033-6","article-title":"The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring","volume":"20","author":"van Slooten","year":"1984","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100470_bib0010","first-page":"62","article-title":"Role of mitotane in adrenocortical carcinoma - review and state of the art","volume":"14","author":"Paragliola","year":"2018","journal-title":"Eur Endocrinol"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100470_bib0011","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1111\/bcp.14721","article-title":"Pharmacological profile and effects of mitotane in adrenocortical carcinoma","volume":"87","author":"Corso","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.clinsp.2024.100470_bib0012","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/0006-2952(95)00028-X","article-title":"Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers","volume":"49","author":"Cai","year":"1995","journal-title":"Biochem Pharmacol"},{"issue":"23","key":"10.1016\/j.clinsp.2024.100470_bib0013","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jchromb.2011.06.001","article-title":"A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients","volume":"879","author":"Garg","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2-3","key":"10.1016\/j.clinsp.2024.100470_bib0014","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0009-8981(87)90141-0","article-title":"Use of GC\/MS\/SIM for rapid determination of plasma levels of o,p'-DDD, o,p'-DDE and o,p'-DDA","volume":"170","author":"Inouye","year":"1987","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100470_bib0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-4347(87)80122-6","article-title":"Rapid micromethod for the analysis of mitotane and its metabolite in plasma by gas chromatography with electron-capture detection","volume":"417","author":"Benecke","year":"1987","journal-title":"J Chromatogr"},{"key":"10.1016\/j.clinsp.2024.100470_bib0016","unstructured":"A framework for using CLSI documents to evaluate medical laboratory test methods, 3rd Edition, EP 19."}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224001479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224001479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T04:41:26Z","timestamp":1735792886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593224001479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":16,"alternative-id":["S1807593224001479"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100470","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a liquid chromatography coupled to a diode array detector (LC-DAD) method for measuring mitotane (DDD) in plasma samples","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100470"}}